Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimers disease and diabetes
"One supplement I recommend avoiding on GLP-1 is fat-burning products or those with stimulants
AI can also combine a patient's GLP-1 treatment duration, rate of weight loss, bone density score, and vitamin D levels to generate a personalized bone fracture risk score, tailoring the recommendation for calcium/vitamin D supplementation or the timing of a bone density check
Simple adjustments to eating habits, hydration, and activity levels can make a big difference
If you have Medicare insurance covering it as a diabetes treatment, Ozempic can cost much less
Melanotan 2 activates additional receptors beyond MC1R, resulting in broader systemic responses, such as nausea, appetite suppression, or flushing seen in research environments